-+ 0.00%
-+ 0.00%
-+ 0.00%

Aldeyra Therapeutics Secures Orphan Designation from European Medicines Agency for ADX-2191 to Treat Retinitis Pigmentosa

Reuters·07/24/2025 11:00:44

Please log in to view news